ROCKLAND, Mass.--(BUSINESS WIRE)--BioSphere Medical, Inc. (NASDAQ: BSMD), a medical device company that has pioneered the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations, announced today that Richard Faleschini, President and Chief Executive Officer, is scheduled to present at the Needham & Company, LLC Biotechnology and Medical Technology Conference in New York City, on Wednesday, June 13, 2007 at 9:30 AM Eastern Time.
